The global In Vivo CRO Market size was valued at USD 45.8 billion in 2023, and the market is projected to reach USD 79.3 billion by the end of 2030, with growth at a CAGR of 8.4% during the forecast report 2023-2030.
In vivo, CROs are companies that do research for pharmaceutical, biotechnology, and medical device companies. These services comprise investigating the safety and effectiveness of potential pharmaceuticals and medical technology using live creatures, such as animals.
A variety of services are available in the in vivo CRO market, including operations, specialty research, and testing for safety and efficacy. Due to increased demand from pharmaceutical and biotechnology companies for these services as well as the use of animal models in drug discovery, the industry has recently experienced growth.
There are several different companies in the very competitive in vivo CRO market. Charles River Laboratories International, Inc., Covance Inc., Eurofins Scientific, Envigo, and WuXi AppTec are a few of the leading competitors on the market. In vivo, CROs are predicted to have a global market worth $3.5 billion in 2020 and $5.8 billion by 2028, according to a study.
There are many dynamic elements that affect the in vivo CRO market, including:
Preclinical research services are more necessary due to the increase in illnesses and disorders that call for the usage of novel, strong medications. Therefore, preclinical research services like in vivo investigations are more in demand.
Technology advancements: New in vivo study procedures and apparatus have been created as a result of technological advancements, boosting the efficacy and precision of the research. As a result, more research is being done, which is fueling the expansion of the in vivo CRO industry.
Strict regulatory requirements: There are strict regulatory processes in place for the approval of drugs and medical equipment. In vivo, studies play a significant role in the regulatory process since they provide crucial information on the safety and efficacy of the goods. The rigorous regulatory restrictions have increased the demand for top-notch in vivo CRO services.
There is a growing need for preclinical models that are more predictive, which has led to an increase in the use of animal models in drug development. Drug discovery has historically utilized animal models.Because animal models are required for the testing and development of novel pharmaceuticals and medical items, the in vivo CRO industry has grown.
Competitive landscape: The in vivo CRO market is highly competitive, with a large number of players ranging from small niche service providers to large multinational companies. This has resulted in intense competition and price pressure, which has influenced the growth and profitability of the market.
As per the report, the global In Vivo CRO Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
by Type
• Rodent-based
• Non-Rodent Based
by GLP Type
• Non-GLP
• GLP Toxicology
by Therapeutic Area
• Autoimmune/Inflammation Conditions
• Pain Management
• Oncology
• CNS Conditions
• Diabetes
• Obesity
• Others
Geographical Classification Analysis:
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Covance Inc.
• Theorem Clinical Research
• WuXi AppTec Inc
• Syneos Health Inc
• Evotec (US), Inc.
• Charles River Laboratories Inc.
*list not exhaustive
1. Executive Summary
1.1 Introduction to In Vivo CRO Markets
1.2 In Vivo CRO Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in In Vivo CRO Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key In Vivo CRO Market Trends
3.2 Key In Vivo CRO Market Growth Drivers
3.3 Key In Vivo CRO Market Growth Restraints
4 In Vivo CRO Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. In Vivo CRO Market Segmentation- Outlook by Type
5.1 Rodent-based Market Outlook to 2030
5.2 Non-Rodent Based Market Outlook to 2030
6. In Vivo CRO Market Segmentation- Outlook by GLP Type
6.1 Non-GLP Market Outlook to 2030
6.2 GLP Toxicology Market Outlook to 2030
7. In Vivo CRO Market Segmentation- Outlook by Therapeutic Area
7.1 Autoimmune/Inflammation Conditions Market Outlook to 2030
7.2 Pain Management Market Outlook to 2030
7.3 Oncology Market Outlook to 2030
7.4 CNS Conditions Market Outlook to 2030
7.5 Diabetes Market Outlook to 2030
7.6 Obesity Market Outlook to 2030
7.7 Others Market Outlook to 2030
8. North America In Vivo CRO Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America In Vivo CRO Market Growth Opportunities
8.3 North America In Vivo CRO Market Outlook by Application
8.4 North America In Vivo CRO Market Outlook by Type
8.5 North America In Vivo CRO Market Outlook by Country
8.6 United States In Vivo CRO Market Outlook
8.7 Canada In Vivo CRO Market Outlook
8.8 Mexico In Vivo CRO Market Outlook
9. Europe In Vivo CRO Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe In Vivo CRO Market Outlook by Application
9.3 Europe In Vivo CRO Market Outlook by Type
9.4 Europe In Vivo CRO Market Outlook by Country
9.5 Germany In Vivo CRO Market Outlook
9.6 France In Vivo CRO Market Outlook
9.7 United Kingdom In Vivo CRO Market Outlook
9.8 Spain In Vivo CRO Market Outlook
9.9 Italy In Vivo CRO Market Outlook
9.10 Other Europe In Vivo CRO Market Outlook
10. Asia Pacific In Vivo CRO Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific In Vivo CRO Market Outlook by Application
10.3 Asia Pacific In Vivo CRO Market Outlook by Type
10.4 Asia Pacific In Vivo CRO Market Outlook by Country
10.5 China In Vivo CRO Market Outlook
10.6 Japan In Vivo CRO Market Outlook
10.7 India In Vivo CRO Market Outlook
10.8 Other Asia Pacific In Vivo CRO Market Outlook
11. Latin America In Vivo CRO Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America In Vivo CRO Market Outlook by Application
11.3 Latin America In Vivo CRO Market Outlook by Type
11.4 Latin America In Vivo CRO Market Outlook by Country
11.5 Brazil In Vivo CRO Market Outlook
11.6 Argentina In Vivo CRO Market Outlook
11.7 Other Latin America In Vivo CRO Market Outlook
12. Middle East and Africa In Vivo CRO Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaIn Vivo CRO Market Outlook by Application
12.3 Middle East and AfricaIn Vivo CRO Market Outlook by Type
12.4 Middle East and AfricaIn Vivo CRO Market Outlook by Country
12.5 Saudi Arabia In Vivo CRO Market Outlook
12.6 UAE In Vivo CRO Market Outlook
12.7 South Africa In Vivo CRO Market Outlook
12.8 Other Middle East and Africa In Vivo CRO Market Outlook
13 Profiles of major In Vivo CRO Companies
Covance Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Theorem Clinical Research
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
WuXi AppTec Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Syneos Health Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Evotec (US), Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Charles River Laboratories Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
by Type
• Rodent-based
• Non-Rodent Based
by GLP Type
• Non-GLP
• GLP Toxicology
by Therapeutic Area
• Autoimmune/Inflammation Conditions
• Pain Management
• Oncology
• CNS Conditions
• Diabetes
• Obesity
• Others